Press Inquiry Form
If you are a journalist, editor, or media representative interested in covering AIMA and our innovations, please fill out the form below. We will get back to you as soon as possible.
A Tool for Diagnostic Optimization
Enhances the accuracy and speed of test interpretation.
Early Access
Suitable for those who monitor their health or are undergoing treatment.
Partner with Aima Diagnostics
Partner with Aima Diagnostics
AI interpretation of laboratory results — built with clinicians, deployed in clinics, and accessible beyond them.
Aima Diagnostics develops AI-powered interpretation of blood test results. Patients upload their results and receive a plain-language report covering biomarker correlations, potentially overlooked abnormalities, and personalized recommendations.
We are expanding our partner network — and we are looking for specific forms of collaboration, not just goodwill.
Who we are looking for — and what you get
Medical professionals & specialists
Help us validate and refine our interpretation models.
→ Co-authorship on publications, early access to the platform, and paid honoraria for data annotation and clinical review.
Clinics & healthcare institutions
Run a pilot of AI interpretation in your practice.
→ Deployment within weeks, no equipment changes, and measurable impact on repeat visits and patient satisfaction. We share the pilot methodology and results.
Case Study: How AI Interpretation Turned One-Time Blood Tests into Repeat Patients
Universities & research centers
Collaborate with us on studies of AI-assisted diagnostics and longitudinal biomarker analysis.
→ Access to anonymized datasets, joint grant applications, and co-supervised research projects.
Nonprofit & philanthropic organizations
Bring diagnostic interpretation to underserved regions where a laboratory report alone may not be enough.
→ We provide the platform; you provide the reach. Partnerships can be structured to meet grant and impact-reporting requirements.
Why partners work with us
How it starts
Every partnership begins with a 30-minute call. There is no commitment beyond that.
→ For clinical and research partners: we discuss your goals and propose a concrete pilot or study design within two weeks.
→ For organizations and investors: we share our impact metrics, roadmap, and current traction.
📩 info@aimamed.ai — tell us who you are and what you would like to build with us.
Aima Diagnostics develops AI-powered interpretation of blood test results. Patients upload their results and receive a plain-language report covering biomarker correlations, potentially overlooked abnormalities, and personalized recommendations.
We are expanding our partner network — and we are looking for specific forms of collaboration, not just goodwill.
Who we are looking for — and what you get
Medical professionals & specialists
Help us validate and refine our interpretation models.
→ Co-authorship on publications, early access to the platform, and paid honoraria for data annotation and clinical review.
Clinics & healthcare institutions
Run a pilot of AI interpretation in your practice.
→ Deployment within weeks, no equipment changes, and measurable impact on repeat visits and patient satisfaction. We share the pilot methodology and results.
Case Study: How AI Interpretation Turned One-Time Blood Tests into Repeat Patients
Universities & research centers
Collaborate with us on studies of AI-assisted diagnostics and longitudinal biomarker analysis.
→ Access to anonymized datasets, joint grant applications, and co-supervised research projects.
Nonprofit & philanthropic organizations
Bring diagnostic interpretation to underserved regions where a laboratory report alone may not be enough.
→ We provide the platform; you provide the reach. Partnerships can be structured to meet grant and impact-reporting requirements.
Why partners work with us
- The product is already in use. This is not simply a proposal for a future study — interpretation is already deployed and its impact can be measured today.
- Human expertise is built in, not added on. Our models are reviewed by practicing clinicians. Partners help shape the product; they do not simply endorse it.
- The social impact is structural. A report people understand is more valuable than a test they cannot interpret. Interpretation helps close the gap between testing and care — especially where access to clinicians is limited.
How it starts
Every partnership begins with a 30-minute call. There is no commitment beyond that.
→ For clinical and research partners: we discuss your goals and propose a concrete pilot or study design within two weeks.
→ For organizations and investors: we share our impact metrics, roadmap, and current traction.
📩 info@aimamed.ai — tell us who you are and what you would like to build with us.